EP1877407A1 - Imidazo(1,2-a)pyridin-derivate zur verwendung als peptiddeformylase-(pdf)-hemmer - Google Patents

Imidazo(1,2-a)pyridin-derivate zur verwendung als peptiddeformylase-(pdf)-hemmer

Info

Publication number
EP1877407A1
EP1877407A1 EP06742662A EP06742662A EP1877407A1 EP 1877407 A1 EP1877407 A1 EP 1877407A1 EP 06742662 A EP06742662 A EP 06742662A EP 06742662 A EP06742662 A EP 06742662A EP 1877407 A1 EP1877407 A1 EP 1877407A1
Authority
EP
European Patent Office
Prior art keywords
group
atom
groups
compounds according
radicals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06742662A
Other languages
English (en)
French (fr)
Inventor
Michael Thormann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Pharma GmbH
Novartis AG
Original Assignee
Novartis Pharma GmbH
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma GmbH, Novartis AG filed Critical Novartis Pharma GmbH
Publication of EP1877407A1 publication Critical patent/EP1877407A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Definitions

  • heteroalkyl groups are groups of formulae R ⁇ O-Y 3 -, R ⁇ S-Y 3 -, R ⁇ N(R 1 O-Y 3 -, R ⁇ CO-Y 3 -, R a -O-CO-Y ⁇ R ⁇ CO-O-Y 3 -, R ⁇ CO-N(R 1 O-Y 3 -, R ⁇ N(R 1 O-CO-Y 3 -,
  • heteroaralkyl refers to an aralkyl group as defined above, in which one or more (preferably 1, 2, 3 or 4) ring carbon atoms and/or carbon atoms are replaced by an oxygen, nitrogen, silicon, selenium, phosphorus, boron or sulfur atom (preferably oxygen, sulfur or nitrogen), i.e. it refers to groups which, in accordance with the above definitions, contain both aryl or heteroaryl, and alky!, alkeny!, alkinyl and/or heteroaiky! and/or cycloalkyl and/or heterocycloalkyl groups.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EP06742662A 2005-04-25 2006-04-24 Imidazo(1,2-a)pyridin-derivate zur verwendung als peptiddeformylase-(pdf)-hemmer Withdrawn EP1877407A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005019180 2005-04-25
PCT/EP2006/003765 WO2006114261A1 (en) 2005-04-25 2006-04-24 Imidazo(1,2-a)pyridine derivatives useful as peptide deformylase (pdf) inhibitors

Publications (1)

Publication Number Publication Date
EP1877407A1 true EP1877407A1 (de) 2008-01-16

Family

ID=36686088

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06742662A Withdrawn EP1877407A1 (de) 2005-04-25 2006-04-24 Imidazo(1,2-a)pyridin-derivate zur verwendung als peptiddeformylase-(pdf)-hemmer

Country Status (10)

Country Link
EP (1) EP1877407A1 (de)
JP (1) JP2008538776A (de)
KR (1) KR20080002866A (de)
CN (1) CN101166740B (de)
AU (1) AU2006239546B2 (de)
BR (1) BRPI0610842A2 (de)
CA (1) CA2606251A1 (de)
MX (1) MX2007013237A (de)
RU (1) RU2409575C2 (de)
WO (1) WO2006114261A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008027812A2 (en) 2006-08-28 2008-03-06 Forest Laboratories Holdings Limited Imidazopyridine and imidazopyrimidine derivatives
US8193214B2 (en) * 2006-10-06 2012-06-05 Boehringer Ingelheim International Gmbh Chymase inhibitors
AU2017366621B2 (en) * 2016-11-28 2021-07-29 Jiangsu Hengrui Medicine Co., Ltd. Pyrazolo-heteroaryl derivative, preparation method and medical use thereof
CN107245050B (zh) * 2016-12-05 2019-10-25 徐州医科大学 香草醛异羟肟酸类衍生物及其应用
US11744824B2 (en) 2020-09-15 2023-09-05 1ST Biotherapeutics, Inc. 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0717971A (ja) * 1993-07-02 1995-01-20 Takeda Chem Ind Ltd イミダゾール誘導体、その製造法及び用途
US6118001A (en) * 1996-08-07 2000-09-12 Darwin Discovery, Ltd. Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
AR029916A1 (es) * 2000-05-05 2003-07-23 Smithkline Beecham Corp N-formil-n-hidroxi-ariloxi alquilaminas y metodos para tratar infecciones bacterianas
UY27813A1 (es) * 2002-05-31 2003-12-31 Smithkline Beecham Corp Inhibidores de la peptido-desformilasa
AU2003296960A1 (en) * 2002-12-11 2004-06-30 Smithkline Beecham Corporation Peptide deformylase inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2006114261A1 *

Also Published As

Publication number Publication date
BRPI0610842A2 (pt) 2010-07-27
RU2409575C2 (ru) 2011-01-20
AU2006239546A1 (en) 2006-11-02
CA2606251A1 (en) 2006-11-02
CN101166740B (zh) 2010-12-29
AU2006239546B2 (en) 2010-04-15
RU2007143501A (ru) 2009-06-10
WO2006114261A1 (en) 2006-11-02
CN101166740A (zh) 2008-04-23
MX2007013237A (es) 2008-01-24
JP2008538776A (ja) 2008-11-06
KR20080002866A (ko) 2008-01-04

Similar Documents

Publication Publication Date Title
EP1877408A1 (de) Imidazo[1,2-a]pyridin-derivate als peptid-deformylase-hemmer
WO2006114261A1 (en) Imidazo(1,2-a)pyridine derivatives useful as peptide deformylase (pdf) inhibitors
EP1893574A2 (de) Peptiddeformylase- (pdf-) inhibitoren 4
ZA200502862B (en) Novel compounds with antibacterial activity
RU2379284C2 (ru) Новые биоизостеры актинонина
US20060122241A1 (en) Novel macrocycles for the treatment of cancer diseases
US20060084614A1 (en) Novel factor viia inhibiting compounds
DE102005026231A1 (de) Peptid-Deformylase (PDF) Inhibitoren 3

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071126

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20100503

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110726